1434TiP MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Catenacci, DV; Strickler, JH; Shitara, K; Nakamura, Y; Janjigian, YY; Barzi, A; Bekaii-Saab, T; Lenz, HJ; Chung, HC; Tabernero, J; Yoshino, T; Siena, S; Mayor, JG; Palanca-Wessels, MC; Xie, D; Marshall, JL

Published Date

  • September 2021

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S1071 - S1072

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2021.08.1543